OBJECTIVES Syringa pinnatifolia var. alashanensis (SP) is a traditional Mongolian medicine. It is widely used for the treatment of cardiovascular disorders. However, the pharmacological mechanisms are still unclear. Our purpose is to investigate the underlying mechanism of the anti-myocardial ischemia effect of ethanol extracts of SP stems.
METHODS The stems of Syringa pinnatifolia var. alashanensis was extracted with 95% ethanol. Model of male C57 mice with left anterior descending (LAD) artery ligated were used to evaluate the antimyocardial ischemia effect. They were divided into four groups (n¼10) randomly by weight as follows: sham group, model group, SP group, and the positive group (aspirin). Echocardiography was performed to determine heart function by EF and FS. CK-MB and LDH in serum, TXB 2 and 6-keto-PGF 1 a in both of plasma and protein homogenate of myocardial tissue were detected. Levels of cyclooxygenase (COX)-1 and COX-2 in heart tissue were tested by western blot. Besides, frozen sections were also used to verify the mechanism.
RESULTS The extracts of SP can significant improve EF (p<0.01) and FS (p<0.01) compared with model group. CK-MB and LDH in SP group were both decreased obviously (p<0.01), approaching to the sham group. Besides, the extract can also upregulate 6-keto-PGF 1 a and decrease TXB 2 in plasma of mice, while in the protein homogenate of the infarction area edge in myocardial tissues levels of the factors are exactly opposite, suggesting that SP extract keeps 6-keto-PGF 1 a and TXB 2 (p<0.01) balanced compared with the model group, which are closer to the sham group compared with aspirin group (P>0.05). Moreover, SP showed an obvious effect on reducing inflammatory cells, which infiltrated in the infarct myocardial tissue. The therapeutic effect of SP is associated with down-regulated expression of COX-1 (p<0.01) and COX-2 (p<0.01).
CONCLUSIONS These results suggest that the ethanol extracts of SP possessing protective effect of anti-myocardial ischemia activity and better than aspirin, via down-regulating the expression of COX-1 and COX-2, and adjusting the imbalance between TXB 2 and 6-keto-PGF 1 a to the normal. This work provided evidence for traditional use of Mongolian medicine and have enormous potential for coronary heart disease (CHD)-clinical application.
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Effects of Ginsenoside Rb1 capsule on Homocysteine-induced endothelial dysfunction and inflammatory response Bin Zhou, Shujie Yu, Zhenda Zheng, Lin Wu, Yong Liu, Baoshun Hao, Zhiming Song, Lin Chen, Xiaoxian Qian Department of Cardiology, The Third Affiliated Hospital, Sun Yat-sen University OBJECTIVES To investigate the effects of Ginsenoside Rb1 on Homocysteine(HCY)-induced endothelial dysfunction and inflammatory response.
METHODS With the informed consents of puerperants, the normal fetal umbilical cords were obtained through uterine-incision delivery in Third Affiliated Hospital, Sun Yat-sun University. HUVECs were isolated by Percoll density gradient centrifugation from fetal umbilical cords with digestion of collagenase typeIperfusion, and then suspended in Medium 199 cultured in 0.05 volume fraction of CO2 incubator at 37 C. After the HUVECs were identified by flow cytometry with the cell marker CD31, The second or third passage was used for study. MTT assay was used to detect cell viability: HUVECs during the logarithmic phase were inoculated in 96-well plates with Medium 199 in 0.05 volume fraction of CO2 incubator at 37 C for 48h, at 80% confluence, incubated in serum-free medium, and divided into two groups, each group including eight parallel wells, blank control group was untreated, the latter cultured and added with HCY of the concentrations of 0.1, 0.25, 0.5, and 1.0 mmol/L respectively, or HCY 0.5mmol/LþRb1 of the concentrations of 10, 20, 40, and 60mmol/L. After the cells were cultured for 24 hr, 5g/L MTT solution (20mL) was added, then dimethyl sulfoxide was used for vibration and dissolvement. Optical density of each hole was detected by using enzymelinked immunosorbent assay to analyze different concentrations of HCY and Rb1 on the proliferation of human mammary stems cells. Western blot was used to examine the protein expression of the cell inflammatory factors, tumor necrosis factor(TNF)-a, interleukin(IL)-6, macrohpage chemoattractant protein(MCP)-1, and intercellular adhesion molecule(ICAM)-1, ELISA was used to detect the contents of the cell inflammatory factors.
RESULTS HCY of different doses inhibited the viability of HUVECs dose-dependently, the inhibition rates of HCY were 0.099AE0.079, 0.239AE0.046, 0.637AE0.007, and 0.553AE0.029 respectively (all P<0.01); the growth rates of HCY-induced HUVECs treatment by Rb1 of the concentrations of 10, 20, 40, and 60mmol/L were 0.682AE0.312, 0.710AE0.040, 0.855AE0.130, 0.784AE0.031 respectively, higher than that of the control group(all P<0.01). Western blotting and ELISA showed that homocysteine significantly increased the expression of TNF-a, IL-6, MCP-1 and ICAM-1, which are 0.71AE0.15, 0.89AE0.32, 0.80AE0.27, 0.54AE012 respectively, higher than that of 0 hour (all P<0.01). However, the expression levels of TNF-a, IL-6, MCP-1 and ICAM-1 of the 0.50mmol/L HCY-induced HUVECs treatment by Rb1 (20mmol/L) were 0.24AE0.04, 0.15AE0.03, 0.13AE0.04, 0.22AE0.06 respectively, not significantly different from those at the of 0 hour (all P>0.01).
CONCLUSIONS Rb1 inhibits homocysteine-induced endothelial impairment and inflammatory response, the definit mechanism of which is expecting advanced study.
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Regulation of lipid metabolism and inflammation response by Danqi Pill through PPARa in coronary heart disease Tianjiao Shi, Qiyan Wang, Chun Li, Jing Wang, Yuan Cao, Wei Wang, Yong Wang Beijing University of Chinese Medicine OBJECTIVES Lipid metabolism disorders and inflammation response play important roles in the pathogenesis of coronary heart disease (CHD). Danqi Pill (DQP) is prescribed routinely in the treatment of CHD. DQP has both anti-inflammatory and lipid-lowering effects. However, its pharmacological mechanisms are not yet fully understood. To provide insights into the pharmacological mechanisms of DQP, we investigated the effects of DQP on PPARa, which regulates lipid metabolism, and inflammatory factors involved in CHD.
METHODS 120 male Sprague-Dawley rats were randomly divided into sham-operated, model group, positive drug-treated group and DQP group. From the day after left anterior descending coronary artery ligation operation, drugs were administered to rats intragastrically for 28 consecutive days. Contents of plasma lipids were evaluated by biochemical examination. Expressions of PPARa, key molecules in lipid uptake-transportation-metabolism pathway (including ApoA1, FABP and CPT1A) and key proteins in inflammation pathway (PLA2, COX2, NF-kB and STAT3) were examined by western blot.
RESULTS Results showed that plasma levels of TG, LDL and VLDL increased, whereas HDL decreased in model group, indicating that plasma lipid metabolism was deregulated. In lipid uptake-transportation pathway, protein levels of Apolipoprotein A1(ApoA1) decreased by 12.6% and fatty acid binding protein (FABP) decreased by 10.0% in model group. Expression of carnitine palmitoyl transferase 1A (CPT1A), which is the key enzyme in lipid utilization, was down-regulated by 28.4%. In PLA-COXs pathway, expressions of PLA2 and COX2 increased by 47.5% and 92.5%, respectively in model group. Expressions of NF-kB and STAT3 were also up-regulated by 35.8% and 113.9% respectively, indicating that inflammatory pathway was activated. PPARa level decreased by 24.3%. In DQP-treated group, lipid disorders were regulated and the indicators returned towards normal levels. Compared to model group, expression of ApoA1 was up-regulated by 59.5% and FABP increased by 29.0% in DQP group. Expression of CPT1A was up-regulated by 54.9%. DQP also inhibited PLA-COXs inflammatory pathway. Compared to model group, expressions of PLA2 and COX2 were down-regulated by 25.1% and 24.8%, respectively. STAT3 expression showed no statistic difference. However, NF-kB level was down-regulated significantly by 56.2%, indicating that the anti-inflammatory effect of DQP is probably mediated by NF-kB. Expression of PPARa in DQP group also increased significantly by 141.3% compared with model group, demonstrating that DQP is an effective agonist of PPARa. 
